Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Clinical and public health implications of glycemic relapse in type 2 diabetes

Nature Clinical Practice Endocrinology & Metabolism volume 3, pages 10–11 (2007)Cite this article

boxed-textGraber AL et al. (2006) Glycemic relapse in type 2 diabetes. Endocr Pract 12: 145–151

To achieve national diabetes care goals, the development of effective clinical and behavioral strategies to prevent relapse among patients who have reached recommended targets is imperative

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Saaddine JB et al. (2006) Improvements in diabetes processes of care and intermediate outcomes: United States, 1988–2002. Ann Intern Med 144: 465–474

    Article  Google Scholar 

  2. No authors listed (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352: 837–853

  3. Sperl-Hillen JM and O'Connor PJ (2005) Factors driving diabetes care improvement in a large medical group: ten years of progress. Am J Manag Care 11 (Suppl): S177–S185

    PubMed  Google Scholar 

  4. Sperl-Hillen JM et al. (2005) Predicting patients who will not sustain A1c goals [abstract]. Diabetes 54 (Suppl 1): A303

    Google Scholar 

  5. O'Connor PJ (2006) Improving medication adherence: challenges for physicians, payers, and policy makers. Arch Intern Med 166: 1802–1804

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Vicky Heath, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. PJ O'Connor and J Sperl-Hillen are Senior Clinical Investigators at HealthPartners Research Foundation, Minneapolis, MN, USA.,

    Patrick J O'Connor & JoAnn Sperl-Hillen

Authors
  1. Patrick J O'Connor
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. JoAnn Sperl-Hillen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Patrick J O'Connor.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

O'Connor, P., Sperl-Hillen, J. Clinical and public health implications of glycemic relapse in type 2 diabetes. Nat Rev Endocrinol 3, 10–11 (2007). https://doi.org/10.1038/ncpendmet0354

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpendmet0354

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing